X

Download Integrating mifepristone PowerPoint Presentation


Login   OR  Register
X

Share page



  Preview

               
Home / Health & Wellness / Health & Wellness Presentations / Integrating mifepristone PowerPoint Presentation

Integrating mifepristone PowerPoint Presentation

worldwideweb By : worldwideweb

On : Aug 07, 2014

In : Health & Wellness

Embed :
515
views

0
downloads
Login / Signup - with account for


  • → Make favorite
  • → Flag as inappropriate
  • → Download Presentation
  • → Share Presentation
  • Slide 1 - Integrating medical abortion into safe abortion services in South Africa Jennifer Moodley Margaret Hoffman
  • Slide 2 - ppt slide no 2 content not found
  • Slide 3 - ppt slide no 3 content not found
  • Slide 4 - Abortion in South Africa Choice on Termination of Pregnancy Act, 1996 < 12 weeks abortion available on request 13-20 weeks Fetus not viable Rape or incest Danger to woman’s physical or mental health Affect woman’s socio-economic status
  • Slide 5 - Abortion in South Africa Designated facility: public, NGO or private 1st trimester- trained registered nurse or physician 2nd trimester- physician only Consent irrespective of age Health worker may refuse to perform, but obliged to inform women of rights and refer
  • Slide 6 - Abortion in South Africa Achievements 90% reduction deaths associated with unsafe abortions Decrease in morbidity associated with abortions Challenges in implementation Lack of designated facilities Shortage of trained personnel
  • Slide 7 - Abortion in South Africa 1997 National guidelines for implementation of TOP stated: “Once medical abortifacients become available in South Africa they should be introduced into the health services to further decentralise services in a safe and effective manner”
  • Slide 8 - Medical abortion in South Africa Lobby group: academics, NGOs, providers, policy makers established 1998 MCC approved mifepristone in 2001 Gestational age less than 56 days Day 1: 600 mg mifepristone Day 3: 400 mcg oral misoprostol (offered home or clinic use) Day 15: Follow-up and final evaluation Medical abortion is available in private sector; not available in public sector
  • Slide 9 - Research Studies: SA Feasibility study profile of TOP clients , the accuracy of gestational age estimation by clinicians and clients compared to ultrasound measurements, the acceptability of medical TOP to clients and providers Operations research Medical TOP provided and the following were assessed: outcome, side effects, rates of follow-up, and acceptability of medical abortion to women and health care providers Costing studies Private sector use
  • Slide 10 - Research studies: key findings Feasibility 22% of TOP clients attended service within 56 days 82% interested in trying medical TOP 77% lived < 1 hour from health service, but rural women travelled for longer Generally policymakers and providers favourable attitudes Gestational age - mean provider estimates were 2 days fewer than u/s estimates. D Cooper et al RHM 2005 K Blanchard et al. BJOG 2007
  • Slide 11 - Research studies: key findings Operations research 90% returned for follow-up visit 93% of women had a complete abortion Majority opted to use misoprostol at home Side-effect – no serious, 66% pain, 67% heavy bleeding 96% women satisfied with procedure Providers satisfied, felt it would decrease their workload and recommended introduction of medical TOP M Kawonga et al J Fam Plann Reprod Health are 2008
  • Slide 12 - Research studies: key findings Costing Main cost drivers are: Dosage – cost increased by 84% when 600mg vs 200mg Level of health care facility – cost increased by 39% when secondary vs primary level facility Category of provider – cost increased by 10% for physician vs nurse Cost of nurse providing MVA at primary level similar to the cost of providing medical abortion with 200 mg mifipristone H De Pinho WHRU, UCT 2000 L CUllingworth et al WHRU, UCT 2002
  • Slide 13 - Research studies: key findings Private Majority of providers also provided surgical abortion, 11.3% were not providing surgical abortion and had incorporated medical TOP into their services Range of regimes used – 84% mifipristone-misoprostol regimes. Of these, 54% used 200 mg mifipristone and 43% used 600 mg. 94% reported that their clients were satisfied with medical TOP K Blanchard et al European Society of Contraception 2006
  • Slide 14 - Current situation MCC approved mifepristone 2001 Available in private sector 300 – 400 packs (3 x 200mg) mifegyn sold per week. Cost R1020 per pack = R340 per 200 mg tablet. Local research has shown that medical abortion can be integrated into the SA public health care sector Provider training guidelines have been developed and are available Providers have been trained
  • Slide 15 - Current situation Draft policy guidelines for the implementation of medical TOP have been developed and submitted to NDOH in 2007 Set standards and norms for provisions of medical TOP Guiding principles with regards to clients, providers and service sites Describe MTOP counseling Provide information on provider training Provide indicators for monitoring and evaluation 2009 – NOT available in public sector
  • Slide 16 - Introducing medical abortion into public health sector Advocacy and education Responding to anti-abortion lobby Responding to news media Change protocol – mifipristone 200mg Challenges
  • Slide 17 - Conclusion Medical abortion can and should be integrated into public sector abortion services in South Africa

Description : Available Integrating mifepristone powerpoint presentation for free download which is uploaded by steve an active user in belonging ppt presentation Health & Wellness category.

Tags : Integrating mifepristone

Shortcode : Get Shareable link